Contents
pdf Download PDF pdf Download XML
628 Views
838 Downloads
Share this article
Research Article | Volume 17 Issue 1 (Jan-Dec, 2024) | Pages 53 - 56
A Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Colchicine versus Oral Isotretinoin in the Treatment of Lichen Planus Pigmentosus
1
Assistant ProfessorDept. of DVL, Amaltas Institute of Medical Sciences, Dewas, M.P
Under a Creative Commons license
Open Access
Received
Feb. 21, 2024
Revised
March 5, 2024
Accepted
March 16, 2024
Published
March 22, 2024
Abstract

Background & Methods: The aim of the study is to study Randomized Controlled Trial Comparing the Efficacy & Safety of Oral Colchicine versus Oral Isotretinoin in the Treatment of Lichen Planus Pigmentosus. Lichen Planus Pigmentosus (LPP) is a chronic pigmentary disorder with limited therapeutic options. Oral isotretinoin & colchicine have been reported to have beneficial effects, but head-to-head comparisons are lacking.

Results: Both groups showed significant improvement in pigmentation. The colchicine group showed a higher rate of marked improvement (≥75% reduction in pigmentation score) compared to isotretinoin (48% vs. 32%, p = 0.04). Adverse effects were mild in both groups, though mucocutaneous dryness was more frequent in the isotretinoin group.

Conclusion: Oral colchicine is a safe & more effective alternative to isotretinoin in treating LPP.

Keywords
Recommended Articles
Research Article
Non-Surgical Management of Giant Condyloma Acuminatum (Buschke-Löwenstein Tumor) in a Hepatitis B Positive Patient: A Comprehensive Case Report and Clinical Review
...
Published: 15/05/2026
Research Article
Role of Serum Adenosine Deaminase in Assessing Severity and Inflammatory Status in Diabetic Foot Patients
...
Published: 06/04/2025
Research Article
A Rare Case Report of Hyaline Fibromatosis Syndrome with an Overlapping Phenotype
...
Published: 15/05/2026
Research Article
Differential Impact of Hepatitis B and C on Insulin Resistance: A Cross-sectional Study
...
Published: 05/04/2025
© Copyright Spejalisci Dermatolodzy